<p>Modeling and simulation of the endogenous CYP3A induction marker 4&beta;-hydroxycholesterol during enasidenib treatment</p>Yan Li, Simon Zhou, Jamie N. Connarn et al.|Clinical Pharmacology Advances and Applications|2019Cited by 9